Literature DB >> 23674349

EGFR: tale of the C-terminal tail.

Ketan S Gajiwala1.   

Abstract

The carboxy terminal tail of epidermal growth factor receptor (EGFR) plays a critical role in the regulation of the enzyme activity of the kinase. There is a good structural model for the mechanism by which the C-terminal tail proximal to the kinase domain contributes to the negative regulation of the activity. Its conformation in the active state, conversely, has remained elusive due to its dynamic nature. A recently published structure of EGFR kinase domain shows the conformation of the proximal C-terminal tail in the active kinase. Analysis of this conformational state of the C-terminal tail is presented, and some of the mutagenesis data is revisited.
Copyright © 2013 The Protein Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23674349      PMCID: PMC3719092          DOI: 10.1002/pro.2283

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  21 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor.

Authors:  Xuewu Zhang; Jodi Gureasko; Kui Shen; Philip A Cole; John Kuriyan
Journal:  Cell       Date:  2006-06-16       Impact factor: 41.582

3.  Epidermal growth factor receptor interaction with clathrin adaptors is mediated by the Tyr974-containing internalization motif.

Authors:  A Sorkin; M Mazzotti; T Sorkina; L Scotto; L Beguinot
Journal:  J Biol Chem       Date:  1996-06-07       Impact factor: 5.157

4.  A highly conserved tyrosine residue at codon 845 within the kinase domain is not required for the transforming activity of human epidermal growth factor receptor.

Authors:  N Gotoh; A Tojo; M Hino; Y Yazaki; M Shibuya
Journal:  Biochem Biophys Res Commun       Date:  1992-07-31       Impact factor: 3.575

5.  A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells.

Authors:  Edgar R Wood; Anne T Truesdale; Octerloney B McDonald; Derek Yuan; Anne Hassell; Scott H Dickerson; Byron Ellis; Christopher Pennisi; Earnest Horne; Karen Lackey; Krystal J Alligood; David W Rusnak; Tona M Gilmer; Lisa Shewchuk
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

6.  BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models.

Authors:  D Li; L Ambrogio; T Shimamura; S Kubo; M Takahashi; L R Chirieac; R F Padera; G I Shapiro; A Baum; F Himmelsbach; W J Rettig; M Meyerson; F Solca; H Greulich; K-K Wong
Journal:  Oncogene       Date:  2008-04-14       Impact factor: 9.867

7.  Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation.

Authors:  Kristina W Thiel; Graham Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

8.  Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor.

Authors:  Jennifer Stamos; Mark X Sliwkowski; Charles Eigenbrot
Journal:  J Biol Chem       Date:  2002-08-23       Impact factor: 5.157

Review 9.  An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors.

Authors:  Antony W Burgess; Hyun-Soo Cho; Charles Eigenbrot; Kathryn M Ferguson; Thomas P J Garrett; Daniel J Leahy; Mark A Lemmon; Mark X Sliwkowski; Colin W Ward; Shigeyuki Yokoyama
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

10.  Architecture and membrane interactions of the EGF receptor.

Authors:  Anton Arkhipov; Yibing Shan; Rahul Das; Nicholas F Endres; Michael P Eastwood; David E Wemmer; John Kuriyan; David E Shaw
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

View more
  9 in total

1.  Biophysical Evidence for Intrinsic Disorder in the C-terminal Tails of the Epidermal Growth Factor Receptor (EGFR) and HER3 Receptor Tyrosine Kinases.

Authors:  Theodore R Keppel; Kwabena Sarpong; Elisa M Murray; John Monsey; Jian Zhu; Ron Bose
Journal:  J Biol Chem       Date:  2016-11-21       Impact factor: 5.157

2.  Coupled regulation by the juxtamembrane and sterile α motif (SAM) linker is a hallmark of ephrin tyrosine kinase evolution.

Authors:  Annie Kwon; Mihir John; Zheng Ruan; Natarajan Kannan
Journal:  J Biol Chem       Date:  2018-02-12       Impact factor: 5.157

3.  Tracing the origin and evolution of pseudokinases across the tree of life.

Authors:  Annie Kwon; Steven Scott; Rahil Taujale; Wayland Yeung; Krys J Kochut; Patrick A Eyers; Natarajan Kannan
Journal:  Sci Signal       Date:  2019-04-23       Impact factor: 8.192

Review 4.  The EGFR family: not so prototypical receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger; Kathryn M Ferguson
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-04-01       Impact factor: 10.005

5.  Constitutive asymmetric dimerization drives oncogenic activation of epidermal growth factor receptor carboxyl-terminal deletion mutants.

Authors:  Angela K J Park; Joshua M Francis; Woong-Yang Park; Joon-Oh Park; Jeonghee Cho
Journal:  Oncotarget       Date:  2015-04-20

6.  Coarse-grained molecular simulation of epidermal growth factor receptor protein tyrosine kinase multi-site self-phosphorylation.

Authors:  John G Koland
Journal:  PLoS Comput Biol       Date:  2014-01-16       Impact factor: 4.475

7.  Preparation of a phosphotyrosine-protein standard for use in semiquantitative western blotting with enhanced chemiluminescence.

Authors:  Nancy Kendrick; Ginny Powers; Jon Johansen; Matt Hoelter; Andrew Koll; Sofia Carlson; Devika Channaveerappa; Costel C Darie
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240

Review 8.  Structure and Dynamics of the EGF Receptor as Revealed by Experiments and Simulations and Its Relevance to Non-Small Cell Lung Cancer.

Authors:  Marisa L Martin-Fernandez; David T Clarke; Selene K Roberts; Laura C Zanetti-Domingues; Francesco L Gervasio
Journal:  Cells       Date:  2019-04-05       Impact factor: 6.600

Review 9.  Structural Insight and Development of EGFR Tyrosine Kinase Inhibitors.

Authors:  Tasia Amelia; Rahmana Emran Kartasasmita; Tomohiko Ohwada; Daryono Hadi Tjahjono
Journal:  Molecules       Date:  2022-01-26       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.